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ABSTRACT: Sulfoxide synthases are non-heme iron enzymes that catalyze oxidative carbon-sulfur bond formation between cys-
teine derivatives and N-a-trimethylhistidine as a key step in the biosynthesis of thiohistidines. The complex catalytic mechanism 
of this enzyme reaction has emerged as the controversial subject of several biochemical and computational studies. These studies 
all used the structure of the g-glutamyl cysteine utilizing sulfoxide synthase, MthEgtB from Mycobacterium thermophilum (EC 
1.14.99.50), as a structural basis. To provide an alternative model system we have solved the crystal structure of CthEgtB from 
Chloracidobacterium thermophilum (EC 1.14.99.51) that utilizes cysteine as a sulfur donor. This structure reveals a completely 
different configuration of active site residues that are involved in oxygen binding and activation. Furthermore, comparison of the 
two EgtB structures enables a classification of all ergothioneine biosynthetic EgtBs into five sub-types, each characterized by 
unique active-site features. This active site diversity provides an excellent platform to examine the catalytic mechanism of sulfox-
ide synthases by comparative enzymology, but also raises the question as to why so many different solutions to the same biosyn-
thetic problem have emerged. 
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INTRODUCTION 
EgtB is a non-heme iron-dependent sulfoxide synthase that participates in the biosynthesis of ergothioneine (1, Figure 1).1-3 EgtB 
catalyses oxidative carbon–sulfur (C-S) bond formation between the imidazole ring of N-a-trimethyl histidine (TMH, 2, Figure 1) 
and g-glutamyl cysteine (g-GC) or cysteine. 2, 4-9 Subsequent oxidation of the sulfur atom concludes the four-electron reduction of 
molecular oxygen (Figure 1) and produces a histidinyl-g-GC sulfoxide conjugate (3, Figure 1) or the histidinyl-cysteine sulfoxide 
conjugate (4). Discovery of EgtB and other ergothioneine biosynthetic enzymes opened new avenues in deciphering the complex 
biological function of this sulfur compound. For example, studies on Mycobacterium tuberculosis, Burkholderia thailandensis and 
Aspergillus fumigates showed that deletion of ergothioneine biosynthetic genes reduces tolerance against oxidative stress, 
suggesting that ergothioneine plays an important role in the redox homeostasis in these pathogenic microorganisms.7, 10-12  
 
From a chemical perspective, EgtB is of particular interest because this enzyme represents an entirely new catalyst type, 
distinguishable from any other oxygen-utilizing enzyme by its reactivity and structure. For example, unlike a-ketoglutarate-
dependent oxygenases which adopt a jelly-roll fold,3, 13 sulfoxide synthases adopt a two-domain structure containing a C-terminal 
domain related to the copper-dependent formylglycine generating enzyme (FGE-like domain)14-15 and a N-terminal domain that is 
most homologous to zinc-dependent thiol-S transferases (DinB_2 domain).16 The crystal structure of EgtB from Mycobacterium 
thermoresistibile (MthEgtB) revealed that the active site is located at the interface between the two domains.1, 17-18  The active site 
hosts a three-histidine facial triad as a metal binding motif, and several residues that are essential for TMH- and g-GC-binding. 
Subsequent biochemical analysis implicated Tyr377 as an essential catalytic residue.17, 19 Mutating Tyr377 to Phe resulted in an 
enzyme that produces g-GC dioxide instead of sulfoxide 4.17 Analogous experiments with the ovothiol biosynthetic sulfoxide 
synthase OvoA showed that this distant relative of MthEgtB uses an equivalent Tyr residue (Tyr417) in the same way.19 Both 
studies concluded that an active site tyrosine plays a pivotal role in steering an early catalytic intermediate towards sulfoxide 
production and away from thiol dioxygenation. However, the mechanism by which Tyr377 or Tyr417 influence reactivity remains 
disputed.17, 20-22  
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Figure 1: Mycobacterial ergothioneine (1) biosynthesis starts with histidine and is catalyzed by the enzymes EgtABCDE (left).2 Thre key reaction, oxida-
tive sulfurization of TMH (2) is catalyzed by a type I EgtB. Other bacteria, such as Chloracidobacterium thermophilum and most fungi utilize a cysteine 
specific type III or IV sulfoxide synthase, in a three-step pathway.4-9 
 
Given the functional importance of Tyr377 we were surprised to find that a large sub-class of EgtB homologs lack this residue.11 
Most of these enzymes are encoded by Proteobacteria but also occur in several species from other phyla (SI Table 1). To 
understand how these EgtB homologs could support ergothioneine production, we examined the crystal structure and kinetic 
behavior of EgtB from Chloracidobacterium thermophilum (CthEgtB). This study highlighted five important differences between 
MthEgtB and CthEgtB. First, CthEgtB uses Cys instead of g-GC as a sulfur donor; secondly, CthEgtB utilizes a tyrosine from the 
N-terminal domain for the exact same function as Tyr377 in MthEgtB; third, the CthEgtB active site employs a second active site 
tyrosine; fourth, a large section of the rigid active site observed in MthEgtB is replaced in CthEgtB by two mobile active site loops 
that fold in a substrate-dependent fashion; finally, all CthEgtB-type EgtBs appear to adopt a D2-symmetric tetrameric quaternary 
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structure. Because of these structural differences to MthEgtB, CthEgtB provides a complementary  study system that may help  to  
solve the emerging controversy about the catalytic mechanism of sulfoxide synthases. Furthermore, comparison between the 
structures of MthEgtB and CthEgtB, compounded by phylogenetic analysis of other homologs illuminates the evolutionary origin 
of sulfoxide synthases and raises the question as to what evolutionary pressures may have given rise to the observed active site 
diversity within the enzyme class of sulfoxide synthases. 
RESULTS 
Crystal structure determination of CthEgtB. The structure of CthEgtB was determined by X-ray crystallography. CthEgtB was 
crystallized as the native protein in complex with iron (II). The crystal diffracted to a resolution of 2.0 Å and belonged to space 
group P21 with four monomers in the asymmetric unit. For data collection and refinement statistics, see Tables S2 and S3, 
respectively. The crystal structure was solved by molecular replacement using a homology model built from the native structure of 
MthEgtB (PDB: 4X8E) as a search model. MthEgtB and CthEgtB share 32 % sequence identity. The electron density revealed a 
continuous polypeptide chain from residues 17 to 434 with the exception of segments 93-98, 183-193, and 377-384 (Figure S1). In 
presence of TMH, CthEgtB was crystallized in space group C2221 with cell constants a, c = 108 Å, b = 200 Å. CthEgtB crystals 
containing TMH were obtained through co-crystallization. The structure of the CthEgtB/Fe/TMH complex was solved to 2.2 Å by 
molecular replacement with the native CthEgtB model. The (2Fo-Fc) electron density map showed well-defined density into 
which two of the previously missing regions (loop 1: residues 93-98 and loop 2: 378-384) could be fitted resulting in a model 
comprising all residues from 7 to 434 aside from residues 183-193 of the linker between the N- and C-terminal domain (Figure 
2A, Figure S2). The TMH ligand could be unambiguously modeled into the (Fo-Fc) difference density map (Figure S3). Data 
collection and refinement statistics are summarized in the supporting information as Table 2 and Table 3, respectively. 
 
CthEgtB forms a stable tetramer. Overall, the tertiary structure of CthEgtB (Fig. 2A) is strikingly similar to that of MthEgtB 
(Fig. S4; r.s.m.d. = 1.2 Å  for 1709 of 2341 aligned), despite the moderate sequence. The most important differences between the 
two homologs are their quaternary structures and the organization of the active sites. In the native CthEgtB crystals, the four 
molecules of the asymmetric unit form a tetramer of D2 symmetry, assembled via two interfaces, each with a two-fold axis (Figure 
2B). The same tetramer is observed in the CthEgtB/TMH crystal, but with one of the molecular dyads coincident with a 
crystallographic 2-fold axis (running along the C-terminal interface). Also in solution, as evidenced by size exclusion 
chromatography, CthEgtB forms a tetramer, in contrast to monomeric MthEgtB 1 (Fig. S5). The N-terminal interface (Fig. 2D) 
occurs between ends of the α-helix bundle N-terminal domain with an interface area of 1310 Å2. Two salt bridges are formed by 
Arg111 and Asp44, while the following residue pairs form hydrogen bonds: Val114 (backbone) and Glu43, Arg111 and Asp44, 
Thr110 and Asp444, Thr171 and Leu108 and Asn172 and Arg111 (backbone). The C-terminal interface (Fig. 2C). spans a slightly 
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smaller area (1094 Å2), and the interacting residues are fewer in number and less conserved. Arg376 and Asp 432 form a salt 
bridge while the residue pairs Ser260 and Lys 388, Tyr308 and Asn392, and two symmetry-related Asn392 residues form 
hydrogen bonds. Residues Thr/Ser110, Arg111, Asn172, Glu43 are conserved in all type II EgtBs (see discussion) suggesting that 
in general type II EgtB might be tetrameric. 
     
Figure 2: Structural and Oligomeric Analysis of CthEgtB in complex with TMH A: Cartoon of the monomeric CthEgtB/Fe/TMH structure. The N-
terminal DinB_2-like domain (residues 17-176) is show in dark blue while the C-terminal FGE-like domain is shown in green (residues 198-234) and light 
blue (residues 235-434). Active site loop 1 (93-99) in red, and active site loop 2 (378-386) in orange, close over the active site. The substrate TMH (yel-
low), iron (orange), chloride ligands (green), iron (brown), and the metal coordinating histidines (blue) are shown to indicate the location of the active site.  
B: View of the tetrameric structure, with two of the three 2-fold axes shown indicating the two different interfaces, the N-terminal & C-terminal interface. 
The third dyad is perpendicular to the page. C, D: Close-up views onto the C-terminal (C) and N-terminal (D) interfaces with interacting residues shown in 
full. Dashed lines indicate H-bonds.  
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Active site of CthEgtB. The structure of CthEgtB in complex with TMH shows that the imidazole rings of His62, His153 and 
His157 form an iron-binding three histidine facial triad, with the Nt of the TMH imidazole ring joining as the fourth. The Np of 
this imidazole ring hydrogen bonds with the backbone carbonyl 385 via a bridging water molecule (Figure 3A). In the native 
structure loop 2 containing Tyr385 is unresolved, suggesting that the presence of TMH immobilizes this loop. The N-a-
trimethylamino moiety of TMH is boxed in by the aromatic rings of Phe415 and Phe416. Furthermore, each of the three N-methyl 
groups also interact with the carbonyl groups of either Phe415 (3.2 Å, backbone), Gln156 (3.2 Å, side chain) or Asn414 (3.4 Å, 
side chain). Comparison to MthEgtB shows that both sulfoxide synthases recognize TMH by an analogous set of interactions 
(Figure 3A & E). 
 
The remaining two coordination sites in the CthEgtB/TMH complex are occupied by residual electron density that is best modeled 
by two chloride ligands: the axial chloride, binding opposite to His156 (Clax), and the equatorial chloride, binding opposite to 
His152 (Cleq). Modelling the two features as water molecules did not sufficiently reduce the residual electron density. While the 
modelled Fe-Cl distances are slightly longer than expected for Fe-Cl bonds (Fe-Clax, Fe-Cleq: 2.5 Å), it has also been noted that 
hydrogen bonding interactions to Cl may be involved in lengthening the Fe–Cl bond.23-24  During catalysis one of these two sites 
must coordinate the second substrate cysteine. However, for reasons that may be related to the flexibility of loop 1 and 2 we were 
unable to obtain crystals of CthEgtB with bound cysteine despite an extensive search for appropriate crystallization and soaking 
conditions. As an alternative, we modelled the CthEgtB/TMH/Cys complex (Figure 3C) using the structure of MthEgtB in 
complex with manganese (II), N-a-trimethyl histidine (DMH) and g-GC as a template (Figure 3E). In MthEgtB the sulfur atom of 
g-GC occupies the axial coordination site (Figure 3E). The cysteinyl carboxylate interacts with Arg87 and Arg90 and the glutamyl 
moiety salt bridges with Asp416 and Arg420. Finally, the amide function of g-GC hydrogen bonds with the carboxylate of TMH. 
The model of the CthEgtB/TMH/Cys complex shows that most of these interactions are conserved. The cysteine carboxylate 
makes a similar interaction with Arg103 and Arg106, and the a-amino group interacts with the carboxylate of TMH (Figure 3C). 
As a key difference, the MthEgtB residues that are responsible for binding the glutamyl moiety of γ-GC, are replaced by Phe416 
and Ala420 in CthEgtB. These two mutations provide a clear structural explanation for the distinct substrate specificity among 
type I and II EgtBs.  
 
The most intriguing structural differences between MthEgtB and CthEgtB map to the presumed oxygen binding site, which is 
occupied by Cleq in the CthEgtB/TMH complex (Figure 3B).1, 20-22 The side chain hydroxyl-groups of Ser92, Tyr93, and Tyr94 of 
loop 1 point towards the presumed oxygen binding site. The b-hydroxyl side chain of Ser92 was resolved in two conformations in 
which the b-hydroxyl side chain hydrogen bonds either with the axial or the equatorial chloride ligands (O-Clax: 2.9 Å, and O-Cleq: 
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3.1 Å) (Figure 3D). The hydroxyl group of Tyr93 makes no direct contact with  Cleq (Cleq-O: 4.0 Å), but instead hydrogen bonds to 
the backbone carbonyl of Tyr385 (2.9 Å), and packs against the imidazole ring of TMH (O-C2: 3.1 Å). The aromatic ring of Tyr94 
makes π–π stacking interaction with Tyr93, and the hydroxyl group of Tyr94 is juxtaposed with the Cleq (Cleq-O: 3.4 Å). Although 
this is a long distance for efficient hydrogen bonding, we note that the Tyr94 hydroxyl group is embedded in a largely 
hydrophobic environment formed by Phe66, Leu382 and Tyr385 providing no alternative hydrogen bonding partners. Hence, 
slight structural adjustments in the reactive complex would allow strong interactions between Tyr94 and iron-bound oxygen.    
 
Figure 3. Structural Comparison of the active site of CthEgtB with MthEgtB. Important metal or substrate binding residues are shown as sticks and are 
colored according domain or segment. Fe is shown in brown, Mn in purple, DMH in yellow, modelled CYS in gray, γ-GC in orange, Cl ions and water as 
spheres in green and red respectively. Upper Panel: A front on view of the active site, focusing on the metal co-ordination sphere and TMH and γ-GC/Cys 
binding sites. Active site loop 1 has been omitted for clarity. Lower panel: This view focuses on the oxygen binding site and is rotated by approximately 
90 °to the left from the front view. Active site loop 2 has been omitted for clarity. A & B: Active site of CthEgtB in complex with iron (II), and TMH. The 
2m|Fo|-D|Fc| omit map for iron, the three histidine ligands, TMH, S92, Y93 & Y94 (red) and the axial (Clax) and equatorial chloride (Cleq) is contoured at 
s-level = 1 . C & D: Cysteine is modelled into to the active site of CthEgtB based on the location of the cysteinyl moiety of γ-GC in MthEgtB. Proposed 
interactions are shown by dashed lines. E & F: Active site of MthEgtB (4X8D) with Y377 pointing towards the proposed oxygen binding site occupied by 
a water molecule (red sphere). 
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The apparent active site geometry of CthEgtB raises two important propositions. Firstly, the presence of Tyr93 and Tyr94 close to 
the presumed oxygen-binding site is highly suggestive of a catalytic role for one or both of these residues. This is interesting 
because the oxygen-binding pocket of MthEgtB contains only one tyrosine (Tyr377). Superposition of the MthEgtB with CthEgtB 
structures shows that the phenol function of Tyr377 is positioned roughly between the phenol functions of Tyr93 and Tyr94 
(Figure 4A). Therefore, based on structural comparisons alone it is impossible to decide which of the two Tyr residues in CthEgtB 
could assume the same catalytic role as Tyr377 in MthEgtB. Secondly, comparison of the CthEgtB native structure and that of the 
CthEgtB/TMH complex show that TMH-induced loop-folding converts a wide-open crevice to a tightly closed pocket. In the 
closed structure the presumed oxygen-binding pocket is completely engulfed by the metal center, the substrates and the side chains 
of Ser92, Tyr93 and Tyr94, suggesting that efficient oxygen-binding may require unfolding of loop 2. Hence, the two CthEgtB 
structures provide evidence that loops 1 and 2 are flexible, and that their folding and unfolding may be obligatory steps in each 
catalytic cycle to allow substrate binding and product release. In MthEgtB oxygen binds to the equivalent equatorial coordination 
site,1, 20-22 but the shape of this pocket is different. This pocket is connected to the protein exterior by a narrow water-filled tunnel. 
Crystal structures of MthEgtB in native form and in complex with TMH or with TMH and g-GC show that this tunnel does not 
change shape upon substrate binding, suggesting that oxygen uptake does not require large-scale conformational change.1  
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Figure 4. Comparison of the catalytic residues of CthEgtB and MthEgtB A): Superposition of the MthEgtB (green) and CthEgtB (red) active sites. The 
iron coordination sphere of Fe in the CthEgtB is shown faintly in the background. Tyrosine residues from MthEgtB (green) and CthEgtB (red) with an 
assigned catalytic function are shown in full. B): Schematic representation of the architecture of MthEgtB & CthEgtB.  
 
 
 
Table 1[a] 
Enzyme kcat,cys[b] 
[s-1] 
KM,cysteine 
[10-6 x M-1] 
kcat,4[c] 
[s-1] 
KM,TMH 
[10-6 x M-1] 
kcat,cys/kcat,4 
CthEgtBwt 0.14 ± 0.05 27 ± 3 0.2 ± 0.01 65 ± 2 1 
CthEgtBY93F  0.16 ± 0.03 120 ± 30 0.0004 ± 0.0001 5 ± 1 400 
CthEgtBY94F 0.021 ± 0.004 34 ± 12 0.003 ± 0.001 35 ± 10 7 
CthEgtBY93F, Y94F 0.049 ± 0.003 90 ± 15 < 0.0001 n.d.[d] > 500 
[a]Kinetic parameters were determined in the presence of 4 uM FeSO4, 2 mM TCEP, 2 mM ascorbate, 100 mM NaCl, 100 mM HEPES, 
pH 8.0 at 26 ℃. Rate determined by monitoring the consumption of cysteine[b], or the production of sulfoxide 4[c]. [d] n.d. = not deter-
mined.  
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Catalytic activity of CthEgtB and variants thereof. We characterized the catalytic activity of CthEgtB using the same HPLC-
based kinetic assay as previously developed for MthEgtB (Table 1).1, 17 In brief, reactions containing TMH, cysteine, iron sulfate, 
tris(2-carboxyethyl)phosphine (TCEP) and ascorbate were initiated by addition of purified CthEgtB. Reaction products were 
analyzed by 1H NMR and RP-HPLC. An initial experiment showed that CthEgtB accepts cysteine to make sulfoxide 4 (Figure 1) 
but cannot turnover g-GC. By monitoring time-dependent production of 4 we determined kcat for sulfoxide production (kcat,4) and 
KM for TMH (KM,TMH) in the presence of 0.5 mM cysteine (Figure S8a).  We also monitored the consumption of cysteine to 
determine kcat,cys and KM for cysteine (KM,cys) in the presence of 0.2 mM TMH (Figure S8b). 1H NMR analysis of reactions that 
initially contained 1 mM TMH and 0.5 mM cysteine showed that wild type CthEgtB oxidizes about 20 % of cysteine to cysteine 
sulfinic acid, and 80 % to sulfoxide 4 (Figure S5 & S6). The same side reactivity has been reported for EgtB from Burkholderia 
thailandensis,11 and OvoA from Erwinia tasmaniensis.19, 25 Mechanistic investigations on MthEgtB and on OvoA from Erwinia 
tasmaniensis showed that this side activity occurs because an early reaction intermediate can react either to form the sulfoxide or 
to form thiol dioxide.17, 19  
 
To probe the catalytic contributions of Tyr93 and Tyr94 we mutated either, or both residues to Phe. 1H NMR analysis of reaction 
mixtures showed that CthEgtBY93F and CthEgtBY94F both produced cysteine sulfinic acid as the main product, and almost no 
sulfoxide 4 (Figure S10 & S11). Subsequent determination of the Michaelis-Menten parameters showed that the Tyr93Phe 
mutation slightly increased the apparent KM for cysteine and reduced the apparent KM for TMH by ten-fold (Table 1). The phenol 
function of Tyr93 makes direct contact with C2 of the TMH imidazole ring (3.1 Å). This interaction may be unfavorable and hence 
deletion of the hydroxyl group in CthEgtBY93F could stabilize the enzyme/substrate complex. Alternatively it is possible that 
KM,TMH is lowered due to a kinetic effect. Because the mutation reduced kcat (see below) relative to the rates of binding and 
unbinding of TMH the value of KM,TMH could approach than of a true binding constant (KD,TMH). Mutation of Tyr94 reduced KM,TMH 
only by two-fold, and caused no significant effect on KM,Cys. Hence, the observed reduction of sulfoxide synthase activity is not 
due to defects in cysteine- or TMH-binding.  
 
On the other hand, the turnover rates (kcat,4) for sulfoxide production were strongly affected in all variants. Mutating Tyr93 reduced 
kcat,4 by 500-fold, but left the rate of cysteine consumption (kcat,cys) essentially unchanged. As evidenced by the NMR analysis 
discussed above, CthEgtBY93F produces almost exclusively cysteine sulfinic acid, instead of sulfoxide 4. Mutating Tyr94 reduced 
sulfoxide synthesis by 70-fold and cysteine consumption by 7-fold. The double mutant showed no detectable sulfoxide production, 
and a cysteine consumption activity only 3-fold less than that of wild type. Summarizing these results we arrive at the following 
conclusions: a) the phenol functions of both active site tyrosines are important for catalysis but are unimportant for substrate 
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binding; b) Tyr93 is more important in determining the product specificity than Tyr94, c) Tyr93 is entirely dispensable for 
oxidative cysteine consumption, d) Tyr94 plays a significant role in oxidative cysteine consumption, e) in the absence of Tyr93, 
Tyr94 supports sulfoxide production at a low but observable rate.  
 
Further evidence that both tyrosines are involved in catalyzing sulfoxide production comes from the fact that both mutations 
induce a significant solvent kinetic isotope effect (sKIE). Measuring sulfoxide production rates in the presence of saturating 
substrate concentrations in either H2O or D2O revealed a sKIE of 1.3 ± 0.2 for the wild type, 2.8 ± 0.2 for CthEgtBY93F and 3.9 ± 
0.2 for CthEgtBY94F (Figure S12) The effects of the Tyr93Phe mutation in catalysis is very similar to those observed for the 
mutation of Tyr377 in MthEgtB, and Tyr417 in OvoA.17, 19  In both cases elimination of this catalytic acid reduced sulfoxide 
synthase activity dramatically, induced a significant sKIE, but did not affect the ability to use oxygen and oxidize thiols. However, 
the presence and catalytic importance of a second tyrosine in CthEgtBB has no correspondence in previously characterized 
sulfoxide synthases. 
 
DISCUSSION 
CthEgtB and MthEgtB catalyze almost identical reactions. Therefore, the structural differences between the two active sites are 
both surprising and informative. The current proposals explaining the catalytic mechanism of sulfoxide synthases were all devel-
oped based on the structure of MthEgtB. As discussed below, reevaluation of these proposals in view of the structure of CthEgtB 
provides a new test that may help to distinguish between different models.  In the second part of the discussion we introduce a 
classification of all known ergothioneine biosynthesis sulfoxide synthase into five types, and we propose a possible evolutionary 
trajectory by which this diversity among extant sulfoxide synthases may have emerged. 
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Figure 5. Top: Catalytic mechanisms proposed for MthEgtB, adapted from Ref. 1, 20 – 22. Two computational studies propose that the reactive 
enzyme/substrate complex (MthEgtB/Fe/TMH/g-CG/O2 complex, red box) first reacts via oxygen atom transfer to the sulfur atom of g-GC (paths 1 & 2). 
Both models predict the formation of sulfoxide 3 with R-configuration at the sulfur atom. 21-22 Two alternative models suggest that the reactive complex 
first reacts via reduction of the superoxide ligand, followed by C-S bond formation between TMH and g-GC (paths 3 & 4). This trajectory leads to 
formation of the sulfoxide 3 with S-configuration.1, 20  Bottom: proposed roles of Tyr93 and 94 in the reactive complex of CthEgtB (CthEgtB 
/Fe/TMHCys/O2 complex, green box, see text).  
  
 
MthEgtB-based proposals for the catalytic mechanism of sulfoxide synthases. The four main proposals for the mechanism of 
MthEgtB catalyzed C-S bond formation (paths 1 – 4, Figure 5) all assume that the enzyme combines with the substrates TMH, g-
GC and oxygen to form an iron (III) superoxide complex as a first intermediate (red box, Figure 5).1, 20-22 Even though enzyme-
path 1
path 2
FeII
S
ON
HN
R
OR
H
FeIII
S
ON
HN
R
O H
R
OH
FeIII
S
O
N
N
H
R
O H
R
OH
FeIII
S
O
O
R
N
HN
COO
N
H
FeIII
S
N
HN
R
R
O
O
H
FeIII
S
ON
HN
R
O
H
R
O
H
OH
H
FeIII
S
N
N
H
R
R
H
O
O
H
O
OH
H
path 3 path 4
Tyr377
Tyr377
Tyr377
Tyr377
N
NHOOC
N
S
R
O
N
NHOOC
N
S
R
O
S-Sulfoxide 3 
R-Sulfoxide 3
Tyr93
Tyr94
FeIII
S
O
OR
N
HN
COO
N
H
O
O
H
H
S-Sulfoxide 4
Tyr93
Tyr94
FeIII
S
O
OH
R
N
HN
COO
N
H
O
O
H
FeII
S
O
H
R
N
HN
COO
N
H
O
O
H
H
O2 H2 O
Tyr94
Tyr93
O H
Tyr377
O
Tyr377
FeIII
S
N
HN
R
R
OH
H
O
FeIII
S
N
HN
R
R
O
H
O
O
Tyr377
H
FeIII
S
N
HN
R
R
O
H
O
 
 
13 
bound iron (III) superoxides are notoriously difficult to detect, growing evidence suggests that these species form as early inter-
mediates in many non-heme iron enzymes.26-31 The disagreement among the four models starts with the next step. Two computa-
tional studies concluded that oxygen transfer to the sulfur atom of g-GC occurs first (paths 1 & 2, Figure 5).21-22  Both models sug-
gest that Tyr377 serves as a proton donor to the iron coordinated oxygen atom (proximal oxygen), after cleavage of the O-O bond. 
Subsequent C-S bond formation between g-GC and TMH produces a sulfoxide with R-configuration (R-sulfoxide 3). This predic-
tion is the weakest aspect of these models because the enzymatic product has been determined to be the S-sulfoxide 3.32 The re-
maining two models, one based on structural and biochemical analysis (path 4), the other based on QM/MM calculations (path 3) 
favor a reaction path where the iron (III) superoxide is first reduced by accepting a proton and an electron. In these models C-S 
bond formation precedes S-O bond formation which leads to the correct sulfoxide stereochemistry. The two models disagree over 
the specific role of Tyr377. The computational analysis identified a low-energy pathway along which the iron (III) superoxide is 
reduced by hydrogen atom transfer from Tyr377 (path 3, Figure 5). However, the calculations also showed that the radical charac-
ter transfers from Tyr377 to the sulfur atom of g-GC en route to the transition state of the C-S bond forming step.  Hence, it re-
mains an open question as to whether oxidation of Tyr377 represents a necessary – on the pathway – step, or whether g-GC and 
Tyr377 share radical character in an equilibrium prior to C-S bond formation. An important feature of this computational model is 
that in the reactive complex Tyr377 retracts form the position observed in the crystal structure and only interacts with the 
iron:oxygen species via an intervening water molecule (Figure 5, path 3). There is no empirical evidence for such a movement. In 
fact, the active site geometry of MthEgtB, and specifically the position of Tyr377 were found invariant among different complexes 
of MthEgtB.1  The last model (path 4, Figure 5) suggests that the iron (III) superoxide is reduced by proton transfer from Tyr377 
and electron transfer from the iron-coordinated g-GC.17 In this way g-GC is directly activated as a radical that can attack the imid-
azole ring of TMH.  
 
Importantly, the four models assign different functions to Tyr377 in the early reaction stage, depending on whether its phenol ring 
interacts with the proximal or the distal oxygen of the iron (II) superoxide species, or whether there is no direct interaction at all. 
The position of Tyr377 as determined by crystallography does not allow a distinction between these models. As discussed below 
CthEgtB provides a related system featuring a tyrosine (Tyr93) residue with the same catalytic functions as Tyr377 that cannot 
interact with the proximal oxygen atom.  
 
Catalytic roles of Tyr93 and Tyr94 in CthEgtB. Our Structural and kinetic observations implicate Tyr93 and Tyr94 as important 
catalytic residues. The phenotypes of the Tyr93Phe mutation –  i)  dramatic reduction of  sulfoxide synthase activity, ii) retainment 
of cysteine oxidation activity, and iii) introduction of a significant sKIE on the residual sulfoxide synthase activity –  match the 
phenotypes induced by the Tyr377 mutation in MthEgtB, and  the Tyr417 mutation in OvoA.17, 19 This evidence supports the con-
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clusion that Tyr93 serves the same catalytic function as Tyr377 and Tyr417 despite their different location in the primary se-
quence, and the different orientation in the active site (Figure 3C & D).  
 
The second tyrosine in the oxygen binding pocket of CthEgtB, Tyr94, introduces a new aspect to the catalytic mechanism of sul-
foxide synthases. Tyr94 is juxtaposed to the coordination site that is either occupied by water, oxygen or, as seen in the crystal 
structure, by Cleq (Figure 3D). This position strongly implicates Tyr94 as a hydrogen bonding partner to iron (II)-bound water or to 
the proximal oxygen of iron (III)-bound superoxide (green box, Figure 5). This interaction is likely strong, because Tyr94 has no 
apparent alternative hydrogen bonding partner. Mutation of this residue affected sulfoxide production by 70-fold, but also reduced 
oxidative cysteine consumption by 7-fold, suggesting that Tyr94 assists the catalytic cycle in two independent steps. First, Tyr94 
plays a supporting role in guiding the iron (III) superoxide towards the sulfoxide production pathway. One way how Tyr94 could 
do so is by hydrogen bonding with the proximal oxygen of the iron (III) superoxide species (Figure 5). This acidic interaction 
would certainly increase the electron affinity of the iron (III) superoxide species and thereby facilitate its reduction in the first cata-
lytic step. The observation of a sizable sKIEs in the Tyr94Phe mutant is consistent with this interpretation: this mutation could 
make the iron (III) superoxide species less oxidative, rendering proton-coupled electron transfer to this species rate limiting. An 
alternative interpretation of the CthEgtBY94F phenotype would be that Typ94 acts as a hydrogen bond donor to Tyr93 to activate 
the later as a catalytic acid. However, in the crystal structure the two phenol groups of Tyr93 and Tyr94 are separated by 4 Å, and 
in the conformation given, do not possess a geometry that could facilitate hydrogen bonding. Direct hydrogen bond between the 
two residues might be weak at best.    
 
Reduced cysteine consumption activity in CthEgtBY94F indicates that Tyr94 is also involved in oxygen binding and activation. The 
Tyr94Phe mutation could affect this activity in two ways: the lack of a proton donor could slow down protonation and removal of 
the iron (II) coordinated hydroxide and thereby slow down oxygen binding (bottom, Figure 5). Alternatively, the lack of a hydro-
gen bond could destabilize the iron (III) superoxide. A similar interaction has been observed in human and murine cysteine dioxy-
genase (CDO, EC 1.13.11.20).33 Although CDOs are entirely unrelated to sulfoxide synthases, the local geometries around the 
catalytic iron center are remarkably similar.17 CDO also coordinate iron (II) by three-his facial triads. In the reactive complex the 
remaining coordination sites are filled by amine- and thiolate-ligands form the substrate cysteine. Finally, addition of oxygen as 
the last ligand gives rise to an iron (III) superoxide.  CDO also contains a second-coordination sphere tyrosine (Tyr157) that hy-
drogen bonds with the iron-coordinated oxygen.34-35 Mutation of Tyr157 to Phe resulted in 8 - 20-fold reduction of dioxygenase 
activity, showing that Tyr157  – similar to Tyr94 in CthEgtB – is important but not crucial for the oxygen activation by CDO.33, 36 
The double mutant CthEgtBY93F, Y94F lacks any measurable sulfoxide synthase activity, and oxidizes cysteine 3-fold less efficiently 
than wild type or CthEgtBY93F (Table 1). This activity pattern shows that the Tyr93Phe and Tyr94Phe mutations lead to additive 
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effects, and that the two Tyr residues have limited capacity to compensate for the absence of each other. Hence the two tyrosines 
must play complementary roles that are related to their specific position relative to the oxygen binding site. 
 
A tyrosine residue near the oxygen binding site of non-heme iron enzyme automatically raise the question as to whether this resi-
due participates in the redox chemistry. Oxygen can react with ferrous iron to produce highly reactive species that could oxidize 
the comparatively electron-rich tyrosine side chain. Oxidation of active site residues could either be part of the catalytic mecha-
nism, or could lead to maturing or deactivating automodifications.37 The endoperoxide forming enzyme FtmOx1 provides an ex-
ample of redox active tyrosine involved in the catalytic mechanism.38 In the taurine dioxygenase TauD, oxidation of active site 
Tyr73 also occurs but is part of a deactivating side reaction.39 In mammalian CDO the active site Tyr157 is cross-linked with a 
nearby Cys residue (Cys93) as a result of an oxygen-dependent side reaction.40 Since mutation to Phe conserves most of the CDO 
activity, Tyr157 is unlikely to participate as an essential redox partner during cysteine deoxygenation. On the other hand, there are 
also enzymes that use tyrosine side chains to activate and orient iron-bound oxygen species with no apparent redox participation. 
A computational study on the algal prolyl-4-hydroxylase concluded that the  active site tyrosine (Tyr140) controls the reactivity of 
the oxo-ferryl species by hydrogen bonding to the iron bound oxygen atom.41 How Tyr140 evades oxidation remains an open 
question. The same is true for the sulfoxide synthases MthEgtB and CthEgtB. Even though Tyr377 and Tyr93/Tyr94 appear inti-
mately involved with oxygen binding and activation, we have no evidence that these residues participate in any redox activity, and 
it is not yet clear why they do not.  
 
In summary, the structural and kinetic evidence discussed above is consistent with the following interpretation: Catalysis by 
CthEgtB requires two hydrogen bond donors in the oxygen binding site. Tyr94 hydrogen bonds with the proximal oxygen of the 
iron (III) superoxide complex to render this species more oxidative. Tyr93 transfers a proton to the distal oxygen of the iron (III) 
superoxide. This transfer is coupled to electron transfer from the substrate cysteine to form an iron (III) hydroperoxide and a thiyl 
radical (Figure 5). The relative positions of Tyr93 and Tyr94 compounded by their specific functions provide evidence that proton 
transfer occurs to the distal and not to the proximal oxygen. Analogous conclusions based on MthEgtB would be more ambiguous 
because in the available crystal structures Tyr377 adopts a position that allows interaction with either atom of the iron-coordinated 
superoxide (Figure 4). From this point forth, the main tenets of any mechanistic proposal will have to be consistent with the struc-
tures of both sulfoxide synthase types (MthEgtB and CthEgtB). We believe that this test will be of significant help in the elimina-
tion or validation of mechanistic proposals for the sulfoxide synthase catalyzed reaction.   
 
The emergence of sulfoxide synthase diversity. The differences in the active sites of CthEgtB and MthEgtB are also interesting 
from an evolutionary perspective. Apparently, the family of sulfoxide synthases does not comply with the general expectation that 
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essential catalytic residues and active site geometries are conserved among enzymes with similar functions.42 Residues Tyr377 and 
Tyr93 map to completely different locations within the protein scaffold (Figure 4B), despite their identical roles in catalysis. 
Relocation of catalytic residues in enzymes with identical function has been documented both in natural and laboratory protein 
evolution. 42-48 The importance of spatial conservation – rather than conservation in the primary sequence – for catalysis has been 
noted. Functional residue hopping is typically facilitated by conservation of the rest of the active site. By contrast, the migration of 
a catalytic tyrosine in CthEgtB (Tyr93) with respect to MthEgtB (Tyr377) is accompanied by the introduction of a second catalytic 
tyrosine (Tyr94), change of substrate specificity, and conversion of a stiff active site (as in MthEgtB) to an open active site 
covered by two flexibles. This complete remodeling raises the question as to what evolutionary path could lie between the two 
catalyst types, and what evolutionary pressure may have caused the conversion from one to the other type. 
 
To address this question and to probe the evolutionary relationships of sulfoxide synthases, we constructed a phylogenetic tree 
based on seven EgtB homologs with characterized activities (Figure 6A).1, 6-8, 17 9 Also, we inspected the alignment of the 
respective sequences for the absence or presence of motifs that are important for function in MthEgtB or CthEgtB (Figure 6B). 
Based on this analysis we distinguished five types of ergothioneine biosynthetic sulfoxide synthase (types I –V). Type I sulfoxide 
synthases utilize gGC, and type II – IV use cysteine as sulfur donor.4-9, 11  Most type IV sulfoxide synthases are OvoA-like 
enzymes that use histidine and cysteine to produce a sulfoxide intermediate in ovothiol biosynthesis.18 However, in the presence of 
TMH OvoA from E. tasmaniensis was shown to produce sulfoxide 3, highlighting the functional similarity of  between EgtBs and 
OvoAs.49 Indeed, the OvoA homologs from Microcystis aeruginosa and other cyanobacteria have evolved to make sulfoxide 3 as 
their main physiological product. Hence, we included this cyanobacterial enzyme as representative of type VI  ergothioneine 
biosynthetic sulfoxide synthase.8 Finally, we also included the cyanobacterial EgtB from Thermosynechococcus elongatus as a 
representative of type V sulfoxide synthases. This type has not been fully characterized yet. Despite significant similarity to type I 
enzymes, the type V EgtBs accept neither cysteine nor g-GC as substrate (Stampfli & Seebeck, unpublished).  
 
Comparing these five enzyme types we arrived at the following conclusions (Figure 6): i) the motifs for iron and TMH binding are 
conserved in all types, ii) tyrosines equivalent to Tyr377 in MthEgtB are conserved except in type II; iii) the g-GC-recognition 
motif DXXR motif is exclusive to type I; iv) the RXXR motif that is responsible for g-GC-binding in MthEgtB, and for cysteine-
binding in CthEgtB occur in type I, II, and with slight variation (KXXR) in type V. In contrast, type III and type IV sulfoxide 
synthases lack this motif, suggesting that these enzymes bind cysteine in a completely different mode. Since most types use a 
Tyr377-like catalytic acid and are monomeric enzymes, we conclude that an ancestral sulfoxide synthase most likely shared these 
properties. Type II-IV use cysteine as sulfur donor, arguing that the ancestral enzyme too used this very common sulfur 
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metabolite. But why is the cysteine-binding pocket not conserved among the three types? Why should an ancestral enzyme 
undergo dramatic active site remodeling to arrive at a functionally equivalent solution? A more likely explanation for the 
emergence of thee enzymes with different substrate binding pockets would be that the ancestral sulfoxide synthase used a different 
sulfur donor than cysteine. Possible candidates could be hydrogen sulfite, thiosulfate or thiophosphate. This scenario suggests that 
this ancestral enzyme type (type 0) first entered different bacterial and fungal lineages and then adapted independently to utilize 
cysteine or g-GC for ergothioneine biosynthesis. Consequently, there may not be an evolutionary path directly connecting extant 
(type I - V) sulfoxide synthases. 
A
 
B
 
Figure 6. A: A qualitative phylogenetic tree containing characterised EgtB homologs C. thermophilum,  M. thermoresistibile1, 17, M. aeruginosa8 
A. fumigatus7, S. pombe6, N crassa 9 and uncharacterised T. Elongatus. (… = omitted residues; --- = gaps) B: Sequence alignment of characterized EgtB 
homolgoues C. thermophilum,  M. thermoresistibile1, 17, M. aeruginosa8 A. fumigatus7, S. pombe6, N crassa 9 and uncharacterised T. Elongatus. Residues 
highlighted in red indicate active site loop 1 of CthEgtB. Key residues for binding and catalysis are highlighted and labelled. 
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CONCLUSION 
Based on the crystal structure of CthEgtB in complex with iron (II) and TMH we identified Tyr93 and Tyr94 as essential catalytic 
residues. Mutation of either residue to phenylalanine significantly reduced sulfoxide synthase activity, whereas only the Tyr94Phe 
mutation affected the enzymes ability to consume cysteine. These different phenotypes, compounded by their different positions in 
the oxygen binding pocket provide evidence that Tyr93 serves as a proton donor and Tyr94 serves as a hydrogen bond donor, both 
facilitating the reduction of the initial iron (III) superoxide species. This reduction is the first catalytic step towards sulfoxide 
production. Comparison with the structure of EgtB from M. thermoresistibile (MthEgtB) and with primary sequences of other 
bacterial and fungal homologs revealed that the class of ergothioneine biosynthetic sulfoxide synthases is characterized by 
remarkable active site diversity. Detailed characterization of type I - V sulfoxide synthases will provide a powerful approach 
understand the catalytic mechanism of oxidative C-S bond formation.1, 17, 19 Finally, the observed diversity indicates that these 
sulfoxide synthase types may have emerged from an ancestral enzyme with different substrate specificity than any known extant 
homolog.  
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